New heart device under watch: belgian study monitors EV-ICD performance

NCT ID NCT07156851

Not yet recruiting Knowledge-focused Sponsor: AZ Sint-Jan AV Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This observational study will follow 100 patients in Belgium who have received an extravascular implantable cardioverter-defibrillator (EV-ICD) as part of their routine care. Researchers will collect data from medical records on device performance, complications, and patient outcomes over the device's lifetime. No extra tests or visits are required for participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry will provide real-world data on how well the EV-ICD works and its safety, helping doctors improve care for patients needing defibrillators.
What could go wrong: This is an observational study, not a treatment trial. It only collects data, so it won't directly improve patient outcomes. Results depend on consistent follow-up over many years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)

More trials for these conditions

Other studies related to the condition(s) this trial covers.